Phase I Study of Mosperafenib, a Novel Paradox Breaker B-Raf Proto-Oncogene Serine/Threonine Kinase (BRAF) Inhibitor, in Patients With BRAF V600–Mutant Solid Tumors ASCO Guidelines provide ...

A new clinical practice guideline provides updated recommendations for the treatment of restless legs syndrome. The guideline reflects the latest scientific evidence and recommends significant changes ...

Acute sinusitis leads to more antibiotic prescriptions for U.S. adults than any other condition, but there is no consensus on which antibiotic is preferred for uncomplicated cases. In a retrospective, ...

Objective Inappropriate medication use among surgical patients poses significant risks, including antibiotic resistance, complications, mortality, increased healthcare costs and challenges in pain ...

A new quality improvement initiative demonstrates that evidence-based, clear liquid guidelines can safely reduce fasting windows by 1 hour without increasing aspiration risks. Traditional "6/4/2" ...

Twenty-two percent of U.S. doctors prescribing initial treatment for children with a new diagnosis of anxiety or depression during a recent six-year period chose medications that are not federally ...

Background The indiscriminate use of antibiotics has accelerated antimicrobial resistance (AMR) in Neisseria gonorrhoeae (NG), emphasising the need to follow treatment guidelines. This study aimed to ...

Source: Getty Images The NCCN’s updated guidelines for the treatment of breast cancer include updates on sentinel lymph node biopsy, ovarian function suppression, and the use of prognostic tools. The ...

Expanded eligibility for advanced stroke therapies and new recommendations for diagnosing and treating stroke in children and adults are among the major updates in the new 2026 Guideline for the Early ...

I am writing to provide additional context and research for your article on state cuts to the autism therapy known as applied behavior analysis, or ABA (“It’s the ‘Gold Standard’ in Autism Care. Why ...

The purpose of this non-promotional article is for awareness of recently published data relating to real-world data on treatments, exacerbations, and healthcare burden of bronchiectasis, and is not ...